ATTENTION:
BEFORE YOU READ THE
PROJECT WORK, PLEASE READ THE INFORMATION BELOW. THANK YOU!
TO GET THE FULL
PROJECT FOR THE TOPIC BELOW PLEASE CALL:
08068231953,
08168759420
TO GET MORE PROJECT
TOPICS IN YOUR DEPARTMENT, PLEASE VISIT:
A STUDY ON THE WASTE
MANAGEMENT STRATEGIES OF GLAXO SMITHLINE (GSK) NIGERIA PLC)
ABSTRACT
This study was undertaken to identify
and evaluate the waste reduction management strategies in Glaxo Simithline
(GSK) Nigeria Plc, Lagos. In generating total need to
achieve the objective of the study, the researcher consulted many textbook,
journals, periodicals and paper work. These were renewed and deductions and
additions were made appropriately. The study was also conducted by using
primary and secondary sources of data collection as well as percentage and made
in the data analysis and interpretation. Based on the analysis of data
some findings include that good waste reduction management strategies exist and
these include but not limited to processes improvement strategies emphasis on
efficiency maintenance of plants/equipment and employing qualified trained
personnel. Therefore, this work suggest that the company should
intensify, efforts towards achieving zero waste through establishment of
secondary application for all waster generated.
TABLE OF CONTENTS
CHAPTER ONE
1.0
Introduction
1.1
Background of the study
1.2
Statement of the problem
1.3
Objective of the study
1.4
Research Question
1.5
Research Hypothesis
1.6
Significance of the Study
1.7
Scope of the Study
1.8
Limitation of the study
1.9
Definition of terms
References
CHAPTER
TWO
2.1
Literature of Related Review
2.2 Waste Prevention
Models
2.3 Waste Disposal
Techniques
2.4 Waste
minimization strategies
2.5 Case studies on
Waste Minimization
2.6 Basel convention
on Waste Management
2.7 Overview of
facility- Glaxo smithline Nigeria Plc
2.8 Existing Waste
Management strategies by (GSK)
References
CHAPTER THREE
Research Methodology
3.0 Introduction
3.1 Source of Data
3.2 Study Population
3.3 Sampling size
Determination
3.4 Sampling
Procedure
3.5 Data Collection
Instrument
3.6 Method of Data
Analysis
3.7 Decision Rule
3.8 Validity and
Reliability of
Instrument
References
CHAPTER FOUR
4.0 Data Presentation
and Analysis
4.1 Presentation and
Analysis of Data
4.2 Hypothesis
Testing
4.3 Summary of
Result
CHAPTER FIVE
Summary of Findings, Conclusion and
Recommendation
5.1 Summary of
Findings
5.2 Conclusion
5.3 Recommendation
Bibliography
Appendix
CHAPTER ONE
1.0
INTRODUCTION
1.1
BACKGROUND OF THE STUDY
Glaxo Smithkline
(GSK) Nigeria Plc, is a corporate organization, which was incorporated in
Nigeria as a public limited liability company in 1971. Currently it has tow
factories located in Agbara and Ilupeju, GS is quoted on the Nigeria stock
market and is positioned to be the leading pharmaceutical company in Nigeria GS
line of product include
A.
Analgesics; Panadol, Panadol Extra, Cotenol, Phensix and Phensicplus.
B.
Nutritional drinks: Lucozads, lucozade boest etc
C.
Multivitamin tonic: Extravite
D. Laxatives:
Andrews liver salt.
E. Oral
care: Macleans
The analgesics, multivitamin tonic and
laxatives are manufactured at the Ilupeju factory, while the Agbara orsal care
is under contract manufacture with UACP and PP as an embodiment of it’s valves
GS integrates environment and safety into the very fabric of the business to
benefit her various customers and to achieve:
-
Compliance with all applicable laws, regulations legislation and GS environment
and safety standards
-
A work culture that promotes a safe work place characterized by absence of
occupation injures and illnesses.
-
Safe and environmentally responsible development and manufacture of her
products.
-
Protection of the environment through the optimal utilization of resources and
prevention of any adverse impact on the environment and the global community.
-
Worldwide leadership in the industry with a superior environment and safety
vision: the foundation of a environment and safety programmes is set out in
policy statement, which commits GS to
-
Improve efficiency and reduce waste
-
Maximize the efficient use of energy.
-
Design packaging to minimize resources uses and maximize recycling
capabilities.
-
Operate responsibility and cooperatively with the community (Hagan,
2000).
There also, exist standards, covering
emissions to air and water, waste disposal and energy usage in GSK
Nigeria Plc generally, there exist following requirements:
-
Identification and classification of waste
-
Waste generation rates
-
Segregation and storage of waste
-
Identification and selection of waste recycling, recovery storage and disposal
options
-
Transportation of waste
-
Waste disposal contractor management
-
Documentation and record keeping
-
Management of waste produced by contractors working for GSk
All manufacturing process are usually
accomplained with by waste generation. In GSK sources of waste include the
various raw and packaging materials, chemical and chemical products,
intermediate and finished products, metal scraps, sand, spent grease oil,
gaseous emissions/fumes petrochemical and domestic wastes.
These waste are commonly categorized into three forms viz solid waste,
liquid/effluent waste, and sem-solid (paste form) waste.
These forms of waste
could be hazardous or non-hazardous. The hazardous waste include:
a) Waste
solvents – eg tablets/powers/liquid/or pastes destroyed by soaking and diluting
with water, manufacturing floor washings, mopped up spill etc
-
All waste laboratory chemicals-resulting from analysis expired chemical etc
-
Use of asbestos and metals (equipment scrape/spare parts)
The non-hazardous
waste include but not limited in packaging waste paper, plastic, food.
Waste management including strategies has been a global concern and its
effect on environment is currently top on international agenda. To this effect
GSK budget and spends an average of N2.5 million on waste management annually.
1.2
STATEMENT OF THE PROBLEM
Waste is an
inevitable problem, and penalty is paid by industrialized and industrializing
nations. Effort have been geared towards the treatment, disposal and
management of waste with the driving objective of improving current health and
environmental impacts.
A most promising step
in solving various waste problems is the prevention of waste at
it’s source.
Pharmaceutical
industries have been identified as one of the major culprist in the issue of
waste mismanagement. This is considering the kind of hazardous and
non-hazardous substances produced from their activities and which have also led
to serious problems to both the industry and society at large, like economic
financial loss, pollution/epidemic and even death. It is important to access
how these problems arise.
1.3
OBJECTIVE OF THE STUDY
Various waste
reduction strategies have been adapted by different communities/organizations
in the economy but now effective these strategies have been over the years
shall be major focus of this study. In this, with this, the study objectives of
this work will include:
1) To
ascertain the extent to which firms plan and disposal of their wastes.
2) To
critically appraise the methods of waste disposal in Galxo Smithklin Nigeria
Plc, Lagos.
3) To
highlight the likely consequences of poor waste management in GSK in
particular, and the nation at large.
4) To
ascertain the organizational variable that will make for effective waste
management.
5) To
highlight the potential benefits of effective waste management in GSK.
6) To add
to the existing knowledge in the field so as to assist in further research.
1.4
RESEARCH QUESTION
1) Do
firms actively plan and engage in waste disposal and management?
2) Is
poor waste management a major cause of firms – mortality in the pharmaceutical
industry?
3) Is
waste reduction part of the social responsibility of the company?
4) Are
the waste management strategies Glaxo Smithkline pharmaceutical industry
effective?
5) What
other ways could the company use for effective management of waste in the
industry?
1.5
RESEARCH HYPOTHESIS
H0:
Industries do not deliberately plan for waste disposal and management.
H1:
Adequate was disposal and management is a major planning decision in the
Pharmaceutical industry.
H0:
There is no significant relationship between firms morality in the
pharmaceutical industry and their waste management programs.
H0:
Companies social responsibilities, to not include the issue of waste disposal
and management.
HA:
Companies social responsibilities include effective waste management attract
positive relationship with the firm and public.
1.6
SIGNIFICANCE OF THE STUDY
This research work
has been carried out to serve as a source material for the management of waste
in the waste management industry in particular and the economy as a whole.
Indepth study has
done on area like:
-
Identifying ways of optimizing existing processes
-
Minimizing emissions and therefore pollution control and abatement costs
-
Company’s image and goodwill, etc
The practical
exposure and operations of firms in the industry, vis-Ã -vis the enormous problems
of waste management which this exercise has given to the researcher is quite
appreciated and of future benefit.
Finally, there is no
doubt that other researchers in this field and Glaxo Smithkline Plc in
particular, will find this work interesting, useful and quite challenging.
1.7
SCOPE OF THE STUDY
For the purpose of
this study, the scope shall be limited to the waste generation, treatment and
disposal with special interest on waste reduction strategies adopted within
Glaxo Smithline Nigeria Plc (Ojota and its factories) over the past decade
during the period under study (early 90’s – 2003). It is possible that some
required data may not have been properly documented but efforts should be made
to historically generate such data, which will be subjected to valid
statistically engineered historical data is subject to verification.
1.8
DEFINITION OF TERMS
1. Waste:
Discarded substance that can no longer be used, and which has no apparent
economic volume.
2. Normal
commercial cycle: Refers to the interest in the management of waste materials
when discarded.
3. Waste
inevarchy: Pyramid of waste treatment options that offer the best available
option in a descending order.
4.
Protimity principle: Waste disposal to sent to the facility nearest to the site
of production.
AFFILIATE LINKS:
Comments
Post a Comment